ESC 365 - Alternative LDL cholesterol lowering strategy vs. high-intensity statin strategy: An individual patient data meta-analysis from the randomized RACING and LODESTAR trials

ESC Premium Access

Alternative LDL cholesterol lowering strategy vs. high-intensity statin strategy: An individual patient data meta-analysis from the randomized RACING and LODESTAR trials

Session: Smaller trials, trial updates, and other studies on lipid therapy

Topic: Lipid-Lowering Agents

Speaker: Professor M. Hong (Seoul, KR)

Event: ESC Congress 2024

Congress Presentation

About the speaker

Professor Myeong-Ki Hong

Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul (Korea (Republic of))

3 presentations

1 follower

4 more presentations in this session

Apolipoprotein A-I infusions and cardiovascular outcomes in patients with acute myocardial infarction and hyperlipidemia

Speaker: Doctor C. Gibson (Boston, US)

Cardiovascular Efficacy of Evolocumab in Patients with Obesity: Updates from FOURIER Trial

Speaker: Doctor Y. Kang (Boston, US)

A randomised, placebo-controlled phase 3 study of plozasiran in patients with familial chylomicronemia syndrome

Speaker: Professor G. Watts (Perth, AU)

ApoA-I Infusions and Burden of Ischemic Events after Acute Myocardial Infarction

Speaker: Doctor G. Chi (Boston, US)

Access the full session

Smaller trials, trial updates, and other studies on lipid therapy

Speakers: Professor M. Hong, Doctor C. Gibson, Doctor Y. Kang, Professor G. Watts, Doctor G. Chi

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources